共 50 条
- [21] LONG TERM RESULTS OF ADALIMUMAB IN BEHCET'S DISEASE [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) : S126 - S126
- [22] HLA-A26 is a risk factor for Behcet's disease ocular lesions [J]. MODERN RHEUMATOLOGY, 2021, 31 (01) : 214 - 218
- [23] Update on ocular Behcet's disease [J]. EXPERT REVIEW OF OPHTHALMOLOGY, 2007, 2 (06) : 957 - 979
- [24] Ocular manifestations of Behcet's disease [J]. JOURNAL FRANCAIS D OPHTALMOLOGIE, 2021, 44 (02): : 196 - 202
- [25] Ocular immunopathology of Behcet's disease [J]. SURVEY OF OPHTHALMOLOGY, 1997, 42 (02) : 157 - 162
- [28] Ocular Involvement in Behcet's Disease [J]. TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2009, 43 : 48 - 53
- [29] Interferon α for ocular Behcet's disease [J]. ACTA OPHTHALMOLOGICA SCANDINAVICA, 1997, 75 (06): : 720 - 722
- [30] Ocular manifestations in Behcet's disease [J]. REVUE DE MEDECINE INTERNE, 2018, 39 (09): : 738 - 745